Histological significance of p53 gene expression in squamous cell carcinoma of the buccal mucosa

被引:10
作者
Jayade B.V. [1 ,6 ]
Bhat K. [2 ]
Patil B.R. [3 ]
Nayak R. [4 ]
Sant A. [5 ]
机构
[1] Dept. of Oral and Maxillofacial Surgery, Karnataka Cancer Therapy and Research Institute, Hubli
[2] Dept. of Microbiology, Maratha Mandal’s Nathagirao G. Halgekar Institute of Dental Science and Research Centre, Belgaum
[3] Dept. of Oncosurgery, Karnataka Cancer Therapy and Research Institute, Hubli
[4] Dept. of Oral Pathology, Maratha Mandal’s Nathagirao G. Halgekar Institute of Dental Science and Research Centre, Belgaum
[5] Dept. of General Pathology, Maratha Mandal’s Nathagirao G. Halgekar Institute of Dental Science and Research Centre, Belgaum
[6] Karnataka Cancer Therapy and Research Institute, Navanagar, Hubli
关键词
Anneroth’s grade; Histology; Immunohistochemistry; Oral squamous cell carcinoma; p53;
D O I
10.1007/s12663-009-0051-6
中图分类号
学科分类号
摘要
Introduction: Oral Squamous Cell Carcinoma (SCC) results from genetic mutations which activate the oncogenes and inactivate the tumor suppressor gene namely TP53. Despite the use of multimodality treatments the prognosis of oral SCC has not changed significantly. Purpose: To evaluate 1) if there is any correlation between the two prognostic indicators i.e. p53 over expression and histological grade of the tumor 2) if any of the parameters of histological grading correlate significantly with p53 over expression. This information would help in understanding the exact role of TP53 gene mutation in cellular progression of oral SCC. Method: Study was conducted on 90 resected specimens of Stage IV SCC of buccal mucosa. Slides from these specimens were evaluated for histological grading by Anneroth’s method and p53 over expression by Immunohistochemistry. Results: Statistically significant co-relation was seen between the total histological grade and p53 over expression. Also 4 individual histological parameters which indicated high cellular turnover were also significantly associated with p53 over expression. Conclusion: TP53 mutation histologically signifies an early event in cellular progression of oral SCC. © 2009, Springer.
引用
收藏
页码:205 / 210
页数:5
相关论文
共 19 条
[1]  
Jhonson N., Schmid S., Franeschi S., Macdonald D.G., Ferlay J., Bouquot J.E., Et al., Squamous Cell Carcinoma, World Health Organisation Classification of Tumors Pathology & Genetics of Head & Neck Tumors IARC, pp. 168-175, (2005)
[2]  
Haraf D.J., Nodzenski E., Brachman D., Mick R., Montag A., Graves D., Vokes E.E., Weichselbaum R.R., Human pappiloma virus and p53 in head and neck cancer: clinical correlates and survival, Clin Cancer Res, 2, 4, pp. 755-762, (1996)
[3]  
Girod S.C., Pfeiffer P., Ries J., Pape H.D., Proliferative activity and loss of function of tumor suppressor genes as ‘biomarkers’ in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma, Br J Oral Maxillofac Surg, 36, 4, pp. 252-260, (1998)
[4]  
Nylander K., Dabelsteen E., Hall P.A., The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck, J Oral Pathol Med, 29, 9, pp. 413-425, (2000)
[5]  
Perez-Ordonez B., Beauchemin M., Jordon R.C., Molecular Biology of Squamous cell Carcinoma of the Head and Neck, J Clin Pathol, 59, 5, pp. 445-453, (2006)
[6]  
Gasco M., Crook T., The p53 network in head and neck cancer, Oral Oncol, 39, 3, pp. 222-231, (2003)
[7]  
Guimaraes D.P., Hainaut P., TP53: a key gene in human cancer, Biochimie, 84, 1, pp. 83-93, (2002)
[8]  
de Oliveira L.R., Ribeiro-Silva A., Zucoloto S., Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma, J Oral Pathol Med, 36, 4, pp. 191-197, (2007)
[9]  
Agarwal S., Mathur M., Srivastava A., Ralhan R., MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications, Oral oncol, 35, 2, pp. 209-216, (1999)
[10]  
Shiraki M., Odajima T., Ikeda T., Sasaki A., Satoh M., Yamaguchi A., Noguchi M., Nagai I., Hiratsuka H., Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer, Mod Pathol, 18, 11, pp. 1482-1489, (2005)